CYP27A1 and type 2 diabetes mellitus: Moreover, a meta-analysis of 66 studies by Hygum et al. showed that both markers of bone formation (osteocalcin) and of bone resorption (CTX) were significantly lower in patients with T2DM than in controls [18].